-
公开(公告)号:EP2633063A2
公开(公告)日:2013-09-04
申请号:EP11837147.5
申请日:2011-10-28
CPC分类号: A61K49/0002 , A61K38/20 , A61K49/0013 , A61K49/0045 , A61K49/04 , A61K51/0491 , A61K51/0495 , C12N15/85 , C12N2710/10043 , C12Q1/6886 , C12Q1/6897 , G01N33/574
摘要: Genetic constructs comprising reporter genes operably linked to cancer specific or cancer selective promoters (such as the progression elevated gene-3 (PEG-3) promoter) are provided, as are methods for their use in cancer imaging, cancer treatment, and combined imaging and treatment protocols. Transgenic animals in which a reporter gene is linked to a cancer specific or cancer selective promoter, and which may be further genetically engineered, bred or selected to have a predisposition to develop cancer, are also provided.